Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.
Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function.The company was founded in 2007 and is based in Newton, Massachusetts, United States.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 4, 2021 | Post-IPO Debt | $25M | 1 | Horizon Technology Finance | — | Detail |
Jun 18, 2018 | Convertable Note | $100M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Horizon Technology Finance | Yes | Post-IPO Debt |
Ocean Equity Partners | — | Convertable Note |